NO306300B1 - 3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler - Google Patents

3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler

Info

Publication number
NO306300B1
NO306300B1 NO960112A NO960112A NO306300B1 NO 306300 B1 NO306300 B1 NO 306300B1 NO 960112 A NO960112 A NO 960112A NO 960112 A NO960112 A NO 960112A NO 306300 B1 NO306300 B1 NO 306300B1
Authority
NO
Norway
Prior art keywords
alkoxycarbonyl
thiadiazinones
drugs
compounds
manufacture
Prior art date
Application number
NO960112A
Other languages
English (en)
Norwegian (no)
Other versions
NO960112D0 (no
NO960112L (no
Inventor
Rochus Jonas
Inge Lues
Norbert Beier
Klaus-Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO960112D0 publication Critical patent/NO960112D0/no
Publication of NO960112L publication Critical patent/NO960112L/no
Publication of NO306300B1 publication Critical patent/NO306300B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO960112A 1995-01-11 1996-01-10 3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler NO306300B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19500558A DE19500558A1 (de) 1995-01-11 1995-01-11 3-Alkoxycarbonyl-thiadiazinone

Publications (3)

Publication Number Publication Date
NO960112D0 NO960112D0 (no) 1996-01-10
NO960112L NO960112L (no) 1996-07-12
NO306300B1 true NO306300B1 (no) 1999-10-18

Family

ID=7751240

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960112A NO306300B1 (no) 1995-01-11 1996-01-10 3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler

Country Status (24)

Country Link
US (1) US5705497A (hu)
EP (1) EP0721950B1 (hu)
JP (1) JP4025377B2 (hu)
KR (1) KR100399541B1 (hu)
CN (1) CN1055691C (hu)
AT (1) ATE165828T1 (hu)
AU (1) AU704493B2 (hu)
CA (1) CA2166854A1 (hu)
CZ (1) CZ292094B6 (hu)
DE (2) DE19500558A1 (hu)
DK (1) DK0721950T3 (hu)
ES (1) ES2120251T3 (hu)
GR (1) GR3027566T3 (hu)
HK (1) HK1010194A1 (hu)
HU (1) HUP9600061A3 (hu)
MX (1) MX9600165A (hu)
NO (1) NO306300B1 (hu)
PL (1) PL183011B1 (hu)
RU (1) RU2162087C2 (hu)
SI (1) SI0721950T1 (hu)
SK (1) SK280532B6 (hu)
TW (1) TW407157B (hu)
UA (1) UA44249C2 (hu)
ZA (1) ZA96177B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
DE19929785A1 (de) 1999-06-29 2001-01-04 Bayer Ag Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung
CA2952160A1 (en) * 2014-08-15 2016-02-18 F. Hoffmann-La Roche Ag 2,2,2-trifluoroethyl-thiadiazines
CN112500353B (zh) * 2020-12-08 2022-11-25 北京晨光同创医药研究院有限公司 一种左西孟旦的前药化合物、制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
DE4041074A1 (de) * 1990-12-21 1992-06-25 Merck Patent Gmbh Thiadiazinonderivate
DE4129062A1 (de) * 1991-09-02 1993-03-04 Merck Patent Gmbh Verfahren zur enantiomerentrennung von 5-hetaryl-1,3,4-thiadiazinonen
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
DE4223537A1 (de) * 1992-07-17 1994-01-20 Merck Patent Gmbh Thiadiazinone
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone

Also Published As

Publication number Publication date
UA44249C2 (uk) 2002-02-15
EP0721950A2 (de) 1996-07-17
CA2166854A1 (en) 1996-07-12
JP4025377B2 (ja) 2007-12-19
PL183011B1 (pl) 2002-05-31
ES2120251T3 (es) 1998-10-16
AU4082696A (en) 1996-07-18
NO960112D0 (no) 1996-01-10
MX9600165A (es) 1997-01-31
AU704493B2 (en) 1999-04-22
JPH08253478A (ja) 1996-10-01
ATE165828T1 (de) 1998-05-15
HK1010194A1 (en) 1999-06-17
KR100399541B1 (ko) 2003-12-31
HUP9600061A2 (en) 1997-10-28
NO960112L (no) 1996-07-12
CZ8096A3 (en) 1996-07-17
EP0721950B1 (de) 1998-05-06
CN1135484A (zh) 1996-11-13
SI0721950T1 (en) 1998-10-31
RU2162087C2 (ru) 2001-01-20
DE59600173D1 (de) 1998-06-10
DK0721950T3 (da) 1999-02-15
DE19500558A1 (de) 1996-07-18
KR960029331A (ko) 1996-08-17
ZA96177B (en) 1996-07-30
CN1055691C (zh) 2000-08-23
CZ292094B6 (cs) 2003-07-16
SK280532B6 (sk) 2000-03-13
US5705497A (en) 1998-01-06
PL312240A1 (en) 1996-07-22
EP0721950A3 (hu) 1996-07-24
HUP9600061A3 (en) 1998-04-28
TW407157B (en) 2000-10-01
SK165295A3 (en) 1996-08-07
GR3027566T3 (en) 1998-11-30

Similar Documents

Publication Publication Date Title
NO306720B1 (no) Sykliske ureaer og analoger som er anvendbare som retrovirale proteaseinhibitorer, farmasöytiske preparater omfattende disse og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
DK426289A (da) Spiroforbindelser og farmaceutisk praeparat indeholdende en saadan forbindelse
MX9306831A (es) Nuevos compuestos heterociclicos.
TNSN99168A1 (fr) Derives d'azetidine, leur preparation et les medicaments les contenant
FI955024A (fi) Uudet piperidiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE143598T1 (de) Arzneimittellösung enhaltend derivate von fk506
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
ATE102604T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
IL90424A0 (en) Cephem derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK393488D0 (da) N-((2-oxopyrrolidin-1-yl)acetyl)piperazinderivater og farmaceutisk praeparat mod senil demens
DK488588D0 (da) Sulfonamid-forbindelser, farmaceutiske praeparater indeholdende disse og anvendelse af forbindelserne til fremstilling af antiarytmiske laegemidler
NO306300B1 (no) 3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler
ITMI910456A1 (it) Composizione farmaceutica per il trattamento della cataratta
DK160488D0 (da) Aebenzazepinsulfonamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne samt benzazepin-forbindelser, der er nyttige som mellemprodukterae
DK148288A (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
DK702788A (da) Thioformamidderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
NO972943L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse
DE3783821D1 (de) Tetracyclische indolderivate.
FI101071B (fi) Menetelmä terapeuttisesti käyttökelpoisten 3,4-dihydroisokinoliini-N-o ksidien valmistamiseksi
DK0850939T3 (da) Ellipticin-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterne

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees